Month: February 2025

CHICAGO, Feb. 10, 2025 (GLOBE NEWSWIRE) — Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that it plans to release financial results for the fourth quarter and fiscal year ended December 31, 2024, before the market opens on Thursday, February 27, 2025. A conference call and webcast with analysts and investors is scheduled for Thursday, February 27, 2025 at 8:30 a.m. ET / 7:30 a.m. CT to discuss the results and answer investor and participant questions.Investors and participants can register in advance for the call by visiting:https://register.vevent.com/register/BI52d3575dc26a4925a98967014fdd307fAfter registering, instructions will be shared on how to join the call for those who wish to dial in. On February 27, 2025, the live webcast...

SOUTH SAN FRANCISCO, Calif., Feb. 10, 2025 (GLOBE NEWSWIRE) — Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of patients with immune-mediated diseases, today announced that Martin Babler, President and Chief Executive Officer of Alumis, will present at the virtual Oppenheimer 35th Annual Healthcare Life Sciences Conference on Tuesday, February 11, 2025 at 3:20 pm ET. A live webcast will be available on the Alumis website in the “Investors” section under the “Events” page. About Alumis Alumis is a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of patients with immune-mediated...

SAN DIEGO, Feb. 10, 2025 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on February 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 105,100 shares of its common stock and granted an aggregate of 9,950 restricted stock unit (“RSU”) awards to 14 new non-executive employees, in each case, under the Crinetics Pharmaceuticals, Inc. 2021 Employment Inducement Incentive Award Plan (the “2021 Inducement Plan”). The stock options and RSUs were granted as inducements material to the employees entering into employment with Crinetics in accordance with Nasdaq Listing Rule 5635(c)(4). The 2021 Inducement Plan is used exclusively for granting equity awards to individuals who were not previously employees of Crinetics,...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA TORONTO, Feb. 10, 2025 (GLOBE NEWSWIRE) — Allied Properties Real Estate Investment Trust (“Allied”) (TSX:AP.UN) announced today that it has agreed to offer, on a private placement basis in each of the provinces and territories of Canada (the “Offering”), $450 million aggregate principal amount of series K senior unsecured debentures that will bear interest at a rate of 4.808% per annum and will mature on February 24, 2029 (the “Debentures”). The Debentures will be issued under Allied’s Green Financing Framework (the “Framework”), which is available on Allied’s website at https://www.alliedreit.com/company/esg/. The Debentures will be sold at par with a yield of 4.808% per annum, and are being offered on an agency basis by a syndicate...

NOT FOR DISTRIBUTION TO THE UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Feb. 10, 2025 (GLOBE NEWSWIRE) — Newcore Gold Ltd. (“Newcore” or the “Company”) (TSX-V: NCAU, OTCQX: NCAUF) is pleased to announce that it has entered into an agreement with Paradigm Capital Inc., as lead agent and sole bookrunner, for and on behalf of a syndicate of agents (collectively, the “Agents”), in connection with a commercially reasonable efforts private placement offering by the Company of up to 32,877,000 units of the Company (the “Units”) issued at a price of $0.365 per Unit for aggregate gross proceeds of up to $12,000,105 (the “Offering”). Each Unit will consist of one common share in the capital of the Company (each, a “Common...

BASE SHELF PROSPECTUS IS ACCESSIBLE, AND PROSPECTUS SUPPLEMENT WILL BE ACCESSIBLE WITHIN TWO BUSINESS DAYS, ON SEDAR+ NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES MONTREAL, Feb. 10, 2025 (GLOBE NEWSWIRE) — Rogers Sugar Inc. (the “Company” or “Rogers Sugar”) (TSX: RSI) announced today a public offering (the “Offering”) of $75,000,000 aggregate principal amount of Eighth Series convertible unsecured subordinated debentures (the “Offered Debentures”), at an offering price of $1,000 per Offered Debenture (the “Offering Price”). The Offered Debentures will bear interest at an annual rate of 6.0% per annum, payable semi-annually on the last day of June and December commencing on June 30, 2025. The Offered Debentures will mature on June 30, 2030 (the “Maturity Date”). The Offering is being made through...

$4.0 million upfront with up to an additional $6.0 million of gross proceeds upon the exercise in full for cash of warrants TAREN POINT, Australia, Feb. 10, 2025 (GLOBE NEWSWIRE) — Fitell Corporation (Nasdaq: FTEL) (“Fitell” or the “Company”), an online retailer of gym and fitness equipment in Australia, today announced the closing of its previously announced registered direct offering of 796,813 ordinary shares and an additional investment right to purchase up to 1,195,220 ordinary shares in the form of warrants, at a purchase price of $5.02 per ordinary share and associated warrant. The warrants have an exercise price of $5.02 per share, are exercisable immediately upon issuance and expire three years following the issuance date. Rodman & Renshaw LLC acted as the exclusive placement agent for the offering. The gross proceeds...